Cette thèse de doctorat intitulée Lu Yang : une esthétique aberrante cherche à étudier dans une perspective à la fois philosophique et conceptuelle la création médiatique de l’artiste chinois Lu Yang (1984-) ( 陆扬) entre les années 2013 et 2020. À travers l’animation digitale, des installations et des performances, l’artiste conceptualise de nouvelles configurations des sexes, des genres, du corps et de la conscience qui échappent aux paramètres de la normativité et qui contribuent à déconstruire et à repenser autrement l’anthropomorphisme. Ces nouvelles configurations des sexes, du corps et de la conscience possèdent la particularité d’être aberrantes. Elles remettent aussi en cause la distinction entre le rationnel et l’irrationnel mais aussi entre ce qui est considéré comme « normal » ou « anormal ». L’hypothèse de la recherche est alors la suivante : l’artiste crée et développe une esthétique aberrante caractérisée par des logiques irrationnelles mais aussi par un imaginaire singulier qui relève de l’étrange, de l’anormal, du monstrueux, et du grotesque. L’esthétique aberrante comme il le sera démontré tout au long de cette thèse, contribue simultanément à faire éclater les normes sociales, à remettre en question et à transgresser les limites et les frontières sexuelles et corporelles et à proposer de nouvelles conceptions et configurations de la subjectivité. Ainsi, les questions fondamentales posées par cette thèse sont les suivantes : comment l’oeuvre médiatique de Lu Yang développe-t- elle une esthétique aberrante ? Quelles sont les fonctions et composantes à la fois visuelles et sonores de cette esthétique ? Que nous révèle cette esthétique du point de vue philosophique et conceptuel mais aussi d’un point de vue politique ? Comment propose-t- elle de nouvelles perspectives critiques sur l’art contemporain chinois ? Mon analyse des films et des performances définit trois modalités distinctes de l’esthétique aberrante qui caractérise ses oeuvres. La première modalité développée dans le premier chapitre, s’associe à la question du sexe et de la reproductivité, à travers ce que je vais nommer le sexe-aberrant. La deuxième modalité repose plutôt sur le corps et explore ses nombreuses déformations à travers ce que je définis comme une esthétique du grotesque. Finalement, la troisième et dernière modalité, repose sur l’esprit et la conscience et cet aspect demeure étroitement lié à l’intérêt de l’artiste pour la neuroscience et le bouddhisme. À partir de ces éléments, je démontrerai alors comment l’artiste crée ce que j’appelle une cosmo- technique aberrante. Le corpus de cette thèse se constitue ainsi des cinq oeuvres suivantes : Uterus Man (2013), Delusional Mandala (2015), Electromagnetic Brainology (2017), Electromagnetic Brainology Brain Control Messenger (2018) et, Delusional World (2020). / This doctoral thesis entitled Lu Yang: An Aberrant Aesthetic analyze through a philosophical and conceptual approach the artwork of Chinese new media artist Lu Yang ( 陆扬) (1984-). The artist creates vibrant and sophisticated live-action films, 3D animation, video games installations, and motion capture performance. In these films and performances, the artist visualizes alternative configurations of sexes, bodies, and minds that challenges normativity while deconstructing anthropocentrism and the boundaries between normality and abnormality. These new configurations of sex, body, and mind are aberrant. The main hypothesis of this research is the following: the artist conceptualizes and create what I call an aberrant aesthetic that is characterized by an irrational logic but also a deviant imagination featuring the grotesque, the bizarre, and the monstrous. Then, the following questions can be asked: how does Lu Yang’s media art develop an aberrant aesthetic? What are the visual and sonic functions and components of this aesthetic? What does this aesthetic reveal to us from a philosophical and conceptual point of view, but also from a political point of view? How does this aesthetic offer new critical perspectives on contemporary Chinese art? My analysis of his films and performances distinguishes three different but interrelated modalities of the aberrant aesthetic. The first modality, developed in the first chapter, is related to sex and reproduction through what I define as the aberrant- sex. The second modality is related to the body and his deformations with what I define as the aesthetic of the grotesque. Finally, the third and last modality, represents the mind. It is associated with the preoccupation of the artist for neurosciences and Buddhism and his obsession with the question of control. Then, the third modality designates what I call an aberrant cosmo-technic. The corpus is constituted of the five following artworks: Uterus Man (2013), Delusional Mandala (2015), Electromagnetic Brainology (2017), Electromagnetic Brainology Brain Control Messenger (2018), and Delusional World (2020).

Bivalent genes are frequently associated with developmental and lineage specification processes. Resolving their bivalency enables fast changes in their expression, which potentially can trigger cell fate decisions. Here, we provide a theoretical model of bivalency that allows for predictions on the occurrence, stability and regulatory capacity of this prominent modification state. We suggest that bivalency enables balanced gene expression heterogeneity that constitutes a prerequisite of robust lineage priming in somatic stem cells. Moreover, we demonstrate that interactions between the histone and DNA methylation machineries together with the proliferation activity control the stability of the bivalent state and can turn it into an unmodified state. We suggest that deregulation of these interactions underlies cell transformation processes as associated with acute myeloid leukemia (AML) and provide a model of AML blast formation following deregulation of the Ten-eleven Translocation (TET) pathway

Le virus Epstein-Barr (VEB) est fortement associé au développement de syndromes lymphoprolifératifs (SLP) en greffe pédiatrique. Ce virus a la capacité d’immortaliser les lymphocytes B et de provoquer leur prolifération incontrôlée chez l’hôte immunodéprimé. Plusieurs études démontrent que le cycle lytique du virus jouerait un rôle primordial dans la genèse des SLP en produisant des particules virales pouvant infecter les cellules B adjacentes. Chez un individu immunodéprimé, ces cellules B nouvellement infectées peuvent donner naissance à une expansion lymphocytaire. Le projet présenté dans ce mémoire fait partie d’un programme de recherche visant à élucider le rôle de l’infection productive par le VEB dans le développement des SLP. L’objectif précis de ce projet est de développer un anticorps monoclonal chimère contre la glycoprotéine gp350 du VEB dans le but de neutraliser le virus et d’ainsi prévenir son entrée dans les cellules B. Notre laboratoire a construit une version chimère de l’anticorps monoclonal murin 72A1, lequel se lie à la gp350 et bloque l’infection. Les premiers essais ont révélé la présence de chaînes non fonctionnelles (aberrantes) dans l’hybridome produisant l’anticorps 72A1. La construction de la chaîne légère authentique est maintenant complète alors que celle de la chaîne lourde est toujours en cours. Le processus de caractérisation de l’anticorps chimère inclura des essais de cytotoxicité à médiation cellulaire dépendante des anticorps (ADCC). Dans cette optique, une lignée cellulaire exprimant de façon stable la gp350 a été établie. Notre anticorps chimère anti-gp350 pourrait éventuellement être utilisé comme thérapie préventive chez les greffés présentant un risque élevé de SLP en empêchant l’infection des cellules B adjacentes. / The Epstein-Barr virus (EBV) is associated with B-cell post-transplant lymphoproliferative disease (PTLD). EBV has the unique property of immortalizing B lymphocytes, thereby causing their uncontrolled proliferation in an immunocompromised host. Certain evidence suggests that EBV productive infection may play a primary role in the genesis of PTLD by generating virus particles which can infect bystander B cells. In an immunocompromised individual, these infected B cells may then give rise to expanding B-cell clones. The project presented in this thesis is part of a research program seeking to elucidate the role of EBV productive infection in the genesis of PTLD. The specific aim of this work was to design a chimeric monoclonal antibody against the EBV envelope glycoprotein gp350 in order to neutralize the virus, thereby preventing entry into B cells. Our laboratory constructed a chimeric version of the murine monoclonal antibody, 72A1, which binds to gp350 and blocks infection. The initial cloning attempts revealed the presence of nonfunctional (aberrant) transcripts in the hybridoma line producing the 72A1 antibody. The chimeric version of the authentic light chain is now completed while the chimeric heavy chain construction is ongoing. As part of the characterisation process for the chimeric antibody, a cell line stably expressing surface gp350 was generated. This gp350-expressing cell line will be used for antibody dependent cellular cytotoxicity assays (ADCC). This anti-gp350 chimeric antibody could be useful as a preventive therapy in transplant patients at high risk for PTLD by blocking the infection of bystander B cells.

Dietary fiber (DF) consumption is related with several healthy benefits such as the decreasing risk of colon cancer development. The DF is not digested by the digestive enzymes and reach to colon where is fermented by the colonic microbiota. The fermentation process releases metabolites as short chain fatty acids (SCFA) such as butyrate, propionate and acetate. Besides the fermentation process, the DF can directly interact with intestinal epithelial cells inducing mechanism that can also be related with the associated DF consumption benefits. The lack of information regarding DF and colon cancer are due to the complexity of both the cancer and the DF structure. The papayas DF are derived from the fruit cell wall, and they are probably naturally modified during ripening through a massive polysaccharide hydrolysis, because papayas show a very fast pulp softening. Due to the lack of information about DF and their beneficial effects to human health as well as the possibility of the natural papaya ripening to modifying the DF presented in the fruit pulp, the present thesis had as the primary objectives: 1) to evaluate how the cell-wall degrading enzymes affect the fruit cell wall solubilization and molecular weight; 2) to investigate the direct effects of the papaya pectin derived from unripe to ripe papayas in cancer cell lines, in galectin-3 interaction and in HEK cells expressing pattern recognition receptors (PRR); 3) to evaluate the human colonic in vitro fermentation using DF from unripe and ripe papayas as substrates; 4) to conduct an in vivo experiment using rats with pre-neoplastic colon lesions while receiving a diet with DF from unripe and ripe papayas. The endopolygalacturonases were the main enzymes acting on the solubilizing papaya cell wall pectin affecting both the papaya firmness and pectin structure. Overall, the papayas DF showed a ripening dependent structureeffects. In the cancer cell lines experiments, the ripe papayas pectin showed a more pronounced effects in inducing cancer cell death, inhibiting cancer cells migration and aggregation, activating PRR as toll-like receptors and inhibiting the pro-metastatic protein galectin-3. The DF from papayas also showed different aspects in colonic in vitro fermentation regarding the DF utilization by the bacteria and the bacteria abundance profile. Lastly, the animals receiving the diet with the DF from ripe papayas had less aberrant crypt foci in colon than the animals that received the DF from unripe papayas or cellulose (AIN-93G DF). Therefore, the study of papaya DF was carried out both during papaya ripening and its biological effects in vitro and in vivo, generating unprecedented results relating the endogenous biochemical changes of the fruits during maturation with the possible beneficial effects of their ingestion for health human. / O consumo de fibras alimentares (FA) está relacionado com vários benefícios à saúde como a diminuição no risco do desenvolvimento de câncer de cólon. A FA não é digerida pelas enzimas digestivas do trato gastrointestinal sendo fermentada pela microbiota intestinal do cólon. Como subproduto do processo de fermentação há a liberação de ácidos graxos de cadeia curta (SCFA) - como o butirato, o propionato e o acetato. Além do processo de fermentação, a FA pode interagir diretamente com as células epiteliais do intestino, induzindo mecanismos que também podem estar relacionados com os benefícios associados ao consumo de FA. A falta de informação sobre a FA e o câncer de cólon é, em partes, devido à complexidade de ambos, tanto do câncer quanto da estrutura da FA. As FA do mamão papaia são derivadas da parede celular da fruta apresentando diferentes estruturas dependendo do ponto de amadurecimento do fruto. Esse fato ocorre, pois, durante o amadurecimento do mamão papaia, existe uma extensa hidrólise dos polissacarídeos presentes na parede celular, diminuindo rapidamente a firmeza da polpa do fruto. Devido à falta de informações sobre FA e seus efeitos benéficos à saúde humana que são dependentes da sua estrutura, bem como a possibilidade do amadurecimento do mamão papaia naturalmente modificar as FA presentes na polpa dos frutos, a presente tese teve como principais objetivos: 1) avaliar como as enzimas que degradam a parede celular do mamão papaia afetam a solubilização e o peso molecular da parede celular do fruto; 2) investigar os efeitos diretos da pectina derivada de mamões verdes e maduros em linhagens de células de câncer, na interação com a galectina-3, e em células do tipo HEK que expressam receptores de reconhecimento de padrões (RRP); 3) avaliar a fermentação colônica humana in vitro utilizando as FA de mamões verdes e maduros; 4) avaliar em ratos com lesões pré-neoplásicas no cólon o efeito do consumo de ração com ou sem FA de mamões papaias verdes e maduros. As endopoligalacturonases foram relacionadas como as principais enzimas que atuam solubilizando a pectina da parede celular do mamão, afetando tanto a firmeza da polpa do fruto quanto a solubilização da pectina durante o amadurecimento. De modo geral, as FA dos mamões exerceram um efeito estruturadependente de acordo com a maturação do fruto. Nos experimentos utilizando linhagens de células de câncer, a pectina do mamão papaia maduro apresentou efeitos mais pronunciados na indução da morte e na inibição da migração e da agregação das células, bem como ativando os RRP, como por exemplo, os receptores do tipo toll-like, além de inibir a proteína pró-metastática galectina-3. As FA dos mamões também apresentaram diferentes resultados na fermentação colônica in vitro quanto à utilização das FA pelas bactérias do intestino, e também no perfil de crescimento dessas bactérias. Por fim, os animais que receberam a dieta com as FA dos mamões maduros apresentaram menor incidência de focos de criptas aberrantes do que os animais que receberam as FA provenientes de mamões verdes ou de celulose (FA da ração AIN-93G). Portanto, o estudo das FA dos mamões foi efetuado tanto durante o amadurecimento dos mamões quanto dos seus efeitos biológicos in vitro e in vivo, tendo gerado resultados inéditos relacionando as alterações bioquímicas endógenas dos frutos durante o amadurecimento com os possíveis efeitos benéficos da sua ingestão para a saúde humana.

L’accidentalité des conducteurs de 2RM est au cœur des préoccupations de sécurité routière. Ce travail de thèse vise à apporter des connaissances sur les différences de sexe et de conformité aux stéréotypes de sexe au sein de cette communauté très masculine. Il a été montré que les femmes motocyclistes avaient des taux d’accidents corporels ou mortels bien inférieurs à ceux des hommes. Les résultats montrent que les comportements à risque accidentels des hommes et des femmes motocyclistes sont proches, hormis pour les comportements les plus risqués. Il a aussi été montré que le type de motocyclette avait un effet plus important que le sexe sur les comportements à risques accidentels. De plus, il a été montré que les motocyclistes se conforment aux stéréotypes de sexe qui leurs sont associés et que la masculinité renforce la prise de risque et la transgression des règles, cette relation étant expliquée par les motivations à conduire un 2RM. Enfin, ce travail a montré que les stéréotypes de sexe associés à la conduite d’une motocyclette existent déjà chez les adolescents dès 11 ans. Ce travail de thèse montre donc des différences significatives entre hommes et femmes conducteurs de 2RM, autant au niveau de leur accidentalité que de leurs prises de risque. De plus, des stéréotypes de sexe existent bien pour cette population spécifique d’usagers de la route. Ces travaux permettent d’avoir une connaissance plus fine des comportements des conducteurs de 2RM, et d’enrichir la réflexion sur des actions possibles en matière d’éducation routière, en ciblant les sous-populations les plus à risque chez les conducteurs de 2RM. / The powered two-wheelers (PTW) riders’ accidentality is at the heart of road safety issues. This PhD thesis is part of a comprehensive approach to generate knowledge on sex differences and sex stereotypes conformity within this very masculine stereotyped community. It first showed that female motorcyclists have much lower injury crashes and fatalities rates than males. A first study showed that males declared more intentional risky behaviors and female more non-intentional risky behaviors. A second study showed that the PTW type chosen had a more important effect on the aberrant behaviors than sex. A third study showed that individuals who conformed to masculine stereotypes declared more violations than those who conformed to feminine stereotypes (declared more lapses), whatever their sex. Motivations to ride a PTW explaining this relation. Finally, this work showed that sex stereotypes associated with motorcycle riding already existed on the adolescent population, from the age of 11, even if they are themselves moped riders or if at least one of their parents is a rider. As a conclusion, significant differences between male and female PTW riders were revealed, in terms of accidentology and risk taking. These differences are linked to the riders’ conformity to their sex group and to the effects of this conformity on their motivations to ride a PTW. Moreover, it also showed that sex stereotypes exist for this specific road users’ population. This work led to a more detailed understanding of PTW riders’ aberrant behaviors, and to enrich the thinking for actions with regard to road safety education and prevention.

O composto estudado neste trabalho foi o corante comercial CI Disperse Blue 291 (DB291), que contém o aminoazobenzeno 2-[(2-bromo-4,6-dinitrofenil)azo]-5-(dietilamino)-4-metoxiacetanilida. Esse produto é um azo-corante disperso usado largamente pelas indústrias têxteis para o tingimento de poliéster e pode ser encontrado em ambientes aquáticos oriundo da descarga de efluentes industriais, podendo levar à exposição de humanos por meio da ingestão de água ou alimentos contaminados. Portanto, faz-se importante a avaliação toxicológica do DB291. Este produto apresentou atividade mutagênica para linhagens de Salmonella typhimurium que possuem alta expressão das enzimas nitrorredutase e Ο-acetiltransferase. Tais enzimas também são expressas pelas bactérias da flora intestinal humana e de roedores e, desempenham importante papel na biotransformação de substâncias presentes na luz intestinal. O objetivo deste trabalho foi investigar a atividade do corante DB291 na indução de lesões pré-neoplásicas no cólon de ratos, avaliada pelo teste do cometa e pelo desenvolvimento de focos de criptas aberrantes (FCAs). Resultados com 2, 8, 16 e 24 semanas de tratamento demonstraram que o DB291 não foi capaz de induzir FCAs em ratos tratados por gavage com a dose de 50mg/kg de peso corpóreo, três vezes por semana em dias alternados. Entretanto, resultados com o teste do cometa demonstraram que o corante foi capaz de causar danos ao DNA das células da mucosa do cólon de ratos tratados por via intra-retal. Estes resultados sugerem que o DB291 possui atividade genotóxica in vivo. Considerando a resposta genotóxica para o teste do cometa, a alta atividade mutagênica no teste Salmonella microssoma e o recente relato de que o DP291 causou danos em células de fígado humano (HepG2), faz-se necessário a realização de testes de carcinogênese de longa duração para avaliação segura do seu potencial carcinogênico, não somente em cólon, mas em outros órgãos tais como fígado e bexiga. / The commercial disperse dye product CI Disperse Blue 291 , which contain the aminoazobenzene 2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyacetanilide (CAS registry no. 56548-64-2) is used for polyester fibers dyeing. It can be released in the aquatic environment through the discharge of industrial effluents. Humans can be exposed through the consumption of water and food contaminated with this product therefore its toxicological properties are important to be evaluated. This product showed elevated mutagenic activity with nitroreductase and Ο-acetyltransferase overproducing Salmonella strains. These enzymes are also expressed by human intestinal microflora, making intestines a possible target organ to the development of cancer after exposure to this product. The aim of this study was to investigate the effects of the commercial disperse dye product containing the CI Disperse Blue 291 on rat colon carcinogenesis, evaluated by the single cell gel assay (comet assay) and by aberrant crypt foci development. Results within different experimental periods showed the DB291 were not able to induce preneoplastic lesions in the colon of rats orally treated with 50mg/kg b.w., three times a week. The DB291 induced damages in the DNA of the rats colon mucosa, evaluated by the comet assay. These data indicate that the OB291 showed genotoxic activity in the colon mucosa cells. Considering these results, the mutagenic activity with Salmonella test and the recent data that the OB291 presents toxicity to human liver cells (HepG2), further long time carcinogenesis assays are needed to security evaluation of its carcinogenic potential, not only in colon, but also another organs like liver and kidney.

Le virus Epstein-Barr (VEB) est fortement associé au développement de syndromes lymphoprolifératifs (SLP) en greffe pédiatrique. Ce virus a la capacité d’immortaliser les lymphocytes B et de provoquer leur prolifération incontrôlée chez l’hôte immunodéprimé. Plusieurs études démontrent que le cycle lytique du virus jouerait un rôle primordial dans la genèse des SLP en produisant des particules virales pouvant infecter les cellules B adjacentes. Chez un individu immunodéprimé, ces cellules B nouvellement infectées peuvent donner naissance à une expansion lymphocytaire. Le projet présenté dans ce mémoire fait partie d’un programme de recherche visant à élucider le rôle de l’infection productive par le VEB dans le développement des SLP. L’objectif précis de ce projet est de développer un anticorps monoclonal chimère contre la glycoprotéine gp350 du VEB dans le but de neutraliser le virus et d’ainsi prévenir son entrée dans les cellules B. Notre laboratoire a construit une version chimère de l’anticorps monoclonal murin 72A1, lequel se lie à la gp350 et bloque l’infection. Les premiers essais ont révélé la présence de chaînes non fonctionnelles (aberrantes) dans l’hybridome produisant l’anticorps 72A1. La construction de la chaîne légère authentique est maintenant complète alors que celle de la chaîne lourde est toujours en cours. Le processus de caractérisation de l’anticorps chimère inclura des essais de cytotoxicité à médiation cellulaire dépendante des anticorps (ADCC). Dans cette optique, une lignée cellulaire exprimant de façon stable la gp350 a été établie. Notre anticorps chimère anti-gp350 pourrait éventuellement être utilisé comme thérapie préventive chez les greffés présentant un risque élevé de SLP en empêchant l’infection des cellules B adjacentes. / The Epstein-Barr virus (EBV) is associated with B-cell post-transplant lymphoproliferative disease (PTLD). EBV has the unique property of immortalizing B lymphocytes, thereby causing their uncontrolled proliferation in an immunocompromised host. Certain evidence suggests that EBV productive infection may play a primary role in the genesis of PTLD by generating virus particles which can infect bystander B cells. In an immunocompromised individual, these infected B cells may then give rise to expanding B-cell clones. The project presented in this thesis is part of a research program seeking to elucidate the role of EBV productive infection in the genesis of PTLD. The specific aim of this work was to design a chimeric monoclonal antibody against the EBV envelope glycoprotein gp350 in order to neutralize the virus, thereby preventing entry into B cells. Our laboratory constructed a chimeric version of the murine monoclonal antibody, 72A1, which binds to gp350 and blocks infection. The initial cloning attempts revealed the presence of nonfunctional (aberrant) transcripts in the hybridoma line producing the 72A1 antibody. The chimeric version of the authentic light chain is now completed while the chimeric heavy chain construction is ongoing. As part of the characterisation process for the chimeric antibody, a cell line stably expressing surface gp350 was generated. This gp350-expressing cell line will be used for antibody dependent cellular cytotoxicity assays (ADCC). This anti-gp350 chimeric antibody could be useful as a preventive therapy in transplant patients at high risk for PTLD by blocking the infection of bystander B cells.

O composto estudado neste trabalho foi o corante comercial CI Disperse Blue 291 (DB291), que contém o aminoazobenzeno 2-[(2-bromo-4,6-dinitrofenil)azo]-5-(dietilamino)-4-metoxiacetanilida. Esse produto é um azo-corante disperso usado largamente pelas indústrias têxteis para o tingimento de poliéster e pode ser encontrado em ambientes aquáticos oriundo da descarga de efluentes industriais, podendo levar à exposição de humanos por meio da ingestão de água ou alimentos contaminados. Portanto, faz-se importante a avaliação toxicológica do DB291. Este produto apresentou atividade mutagênica para linhagens de Salmonella typhimurium que possuem alta expressão das enzimas nitrorredutase e Ο-acetiltransferase. Tais enzimas também são expressas pelas bactérias da flora intestinal humana e de roedores e, desempenham importante papel na biotransformação de substâncias presentes na luz intestinal. O objetivo deste trabalho foi investigar a atividade do corante DB291 na indução de lesões pré-neoplásicas no cólon de ratos, avaliada pelo teste do cometa e pelo desenvolvimento de focos de criptas aberrantes (FCAs). Resultados com 2, 8, 16 e 24 semanas de tratamento demonstraram que o DB291 não foi capaz de induzir FCAs em ratos tratados por gavage com a dose de 50mg/kg de peso corpóreo, três vezes por semana em dias alternados. Entretanto, resultados com o teste do cometa demonstraram que o corante foi capaz de causar danos ao DNA das células da mucosa do cólon de ratos tratados por via intra-retal. Estes resultados sugerem que o DB291 possui atividade genotóxica in vivo. Considerando a resposta genotóxica para o teste do cometa, a alta atividade mutagênica no teste Salmonella microssoma e o recente relato de que o DP291 causou danos em células de fígado humano (HepG2), faz-se necessário a realização de testes de carcinogênese de longa duração para avaliação segura do seu potencial carcinogênico, não somente em cólon, mas em outros órgãos tais como fígado e bexiga. / The commercial disperse dye product CI Disperse Blue 291 , which contain the aminoazobenzene 2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyacetanilide (CAS registry no. 56548-64-2) is used for polyester fibers dyeing. It can be released in the aquatic environment through the discharge of industrial effluents. Humans can be exposed through the consumption of water and food contaminated with this product therefore its toxicological properties are important to be evaluated. This product showed elevated mutagenic activity with nitroreductase and Ο-acetyltransferase overproducing Salmonella strains. These enzymes are also expressed by human intestinal microflora, making intestines a possible target organ to the development of cancer after exposure to this product. The aim of this study was to investigate the effects of the commercial disperse dye product containing the CI Disperse Blue 291 on rat colon carcinogenesis, evaluated by the single cell gel assay (comet assay) and by aberrant crypt foci development. Results within different experimental periods showed the DB291 were not able to induce preneoplastic lesions in the colon of rats orally treated with 50mg/kg b.w., three times a week. The DB291 induced damages in the DNA of the rats colon mucosa, evaluated by the comet assay. These data indicate that the OB291 showed genotoxic activity in the colon mucosa cells. Considering these results, the mutagenic activity with Salmonella test and the recent data that the OB291 presents toxicity to human liver cells (HepG2), further long time carcinogenesis assays are needed to security evaluation of its carcinogenic potential, not only in colon, but also another organs like liver and kidney.

Chlamydia trachomatis is the most common sexually transmitted bacterial disease agent worldwide, and, though frequently asymptomatic, can cause extreme pathology including infertility. Chlamydial species exhibit a unique biphasic developmental cycle. Once attached to a cell surface, infectious elementary bodies (EB) are internalized within an inclusion, the membrane-bound structure in which EB transform to noninfectious, replicable reticulate bodies (RB). After multiple rounds of division, RB condense to form EB, which are released and can infect new host cells. In culture, exposure to stressors, such as beta-lactam antibiotics, induce chlamydiae to reversibly detour from normal development into a noninfectious, viable state termed persistence. Cell culture data suggest that persistent forms are resistant to azithromycin (AZM), a front-line antibiotic, and are able to alter the host transcriptome. Though persistence has been described in culture for over 50 years, whether or not it: i) occurs in vivo; and ii) influences chlamydial pathogenesis, transmission and therapy has remained unresolved. To address these questions, we developed an animal model of persistent chlamydial infection using amoxicillin (AMX) treatment. AMX exposure decreased shedding of infectious chlamydiae in C. muridarum-infected mice without affecting chlamydial viability, demonstrating the presence of persistent chlamydiae. Shedding of infectious EB resumed following AMX cessation. Shedding data and microarray analyses suggested that host immunity might limit chlamydia’s exit from persistence in our model. Thus, we hypothesized that cyclophosphamide (CTX) treatment would increase the magnitude of chlamydial shedding observed after AMX-treatment cessation. CTX treatment increased post-AMX shedding by more than 10-fold compared to AMX-only controls. To determine whether persistent chlamydiae are resistant to antibiotic eradication in vivo, we induced persistence by administering AMX and treated mice with various AZM dosing regimes. Persistently infected mice demonstrated increased treatment failure following AZM therapy compared to productively infected controls. These data suggest that persistent chlamydiae are refractory to treatment in vivo and provide an explanation for the observation that treatment fails in some patients. In addition to creating the first fully characterized, experimentally tractable, in vivo model of chlamydial persistence, these experiments provide evidence that persistent/stressed chlamydial forms may serve as a long-term reservoir of infectious organisms in vivo.

La majorité des hyperplasies macronodulaires bilatérales des surrénales avec syndrome de Cushing ACTH-indépendant (AIMAH) est due à l’expression aberrante de divers récepteurs hormonaux au niveau du cortex surrénalien. Les gènes responsables des AIMAH familiales avec récepteurs aberrants n’ont pas été identifiés. Le but de ce projet est de les identifier. Une étude de liaison, visant à identifier la ou les régions du génome comprenant le ou les gènes pouvant être en cause dans les AIMAH familiales, a été réalisée en utilisant l’ADN des membres d’une famille (10 malades et 7 sains) originaire du Québec, atteinte d’AIMAH et syndrome de Cushing et caractérisée par l’expression des récepteurs β-adrénergique et V1-vasopressine. Diverses régions chromosomiques entre les personnes atteintes et non-atteintes de la famille ont été soulignées. Un total de 707453 SNPs a été obtenu, et après analyse statistique, 159 SNPs significatifs, pouvant être associés au phénotype, ont été mis en évidence entre les deux groupes. Il a été constaté que la majorité de ces SNPs se situaient sur les régions chromosomiques 1q32.1 et 16q12.2. Une étude du transcriptome a aussi été réalisée en utilisant l’ADN des tumeurs de deux patients de la famille, ainsi que l’ADN d'autres tumeurs surrénaliennes. Les analyses statistiques ont permis d’identifier 15 gènes susceptibles d’être reliés à la maladie (11 surexprimés et 4 sous-exprimés). En utilisant les données de ces deux études, nous avons ciblé six gènes du chromosome 1 (ATP2B4, PPP1R12B, SOX13, CACNA1S, ADORA1et PHLDA3), un du chromosome 16 (CHD9) et un du chromosome 13 (SPRY2), afin de rechercher la présence de mutations. Le séquençage n’a révélé aucun changement de nucléotide dans les gènes PPP1R12B et SOX13. Dans les gènes ATP2B4, CACNA1S, ADORA1et PHLDA3, le séquençage a révélé des changements de nucléotides n’entrainant soit pas de changement d’acide aminé soit un changement d’acide aminé jugé « non pertinent », du fait qu’il ne permettait pas de différencier les sujets sains des sujets atteints. Pour ce qui est de CHD9 et SPRY2, le séquençage a permis d’identifier des changements de nucléotides entrainant des changements d’acides aminés de façon plus fréquente chez les sujets atteints par rapport aux sujets sains. En conclusion, nos travaux nous ont donc permis d’identifier, par étude de liaison et par analyse du transcriptome, des gènes candidats qui pourraient être responsables de cette pathologie. Le séquençage de ces gènes candidats a révélé des mutations de CHD9 et SPRY2. Ces résultats s’avèrent prometteurs puisque ces deux gènes produisent des protéines impliquées dans le remodelage de la chromatine et dans la régulation de la signalisation des protéines kinases. Le phénotypage et le génotypage des patients atteints doivent être poursuivis pour vérification. / The majority of ACTH-independent macronodular adrenal hyperplasia with Cushing's syndrome (AIMAH) is due to the aberrant expression of various receptors in the adrenal cortex. The genes responsible for familial AIMAH with aberrant receptors have not been identified. The aim of this project is to characterize them. A linkage study to identify the region or regions of the genome comprising the gene or genes that may be involved in familial AIMAH was performed using DNA of family members (10 affected and 7 non affected) born in Quebec and harboring AIMAH and Cushing's syndrome, under the aberrant regulation of B-adrenergic and V1-vasopressin receptors. Various chromosomal regions between patients and non-affected family were highlighted. A total of 707,453 SNPs were obtained, and after statistical analysis, 159 significant SNPs, possibly associated with phenotype, were found between the two groups. It was found that the majority of these SNPs were located on chromosomal regions 1q32.1 and 16q12.2. A transcriptome analysis was conducted using DNA from tumours of two patients of the family, as well as DNA from other adrenal tumours; Statistical analysis identified 15 genes that may be linked to disease (11 up-regulated and 4 under-expressed). Using data from these two studies, we identified six genes on chromosome 1 (ATP2B4, PPP1R12B, SOX13, ADORA1, CACNA1S and PHLDA3), one on chromosome 16 (CHD9) and one on chromosome 13 (SPRY2), to investigate the presence of mutations. The sequencing revealed no nucleotide changes in gene PPP1R12B and SOX13. In ATP2B4, CACNA1S, ADORA1 and PHLDA3, the sequencing not revealed nucleotides changes leading to either amino acid changes or an amino acid changes considered “not-relevant”, because they do not differentiate healthy individuals from affected. The sequencing of CHD9 and SPRY2 identified nucleotide changes causing amino acid changes more frequently in patients compared to healthy subjects. In conclusion, our work has therefore identified by linkage analysis and DNA microarray candidate genes that can be responsible to this disease, and mutations in two of these genes, CHD9 and SPRY2. These results are promising because these genes produce proteins involved in chromatin remodeling and regulation of signaling protein kinases. Phenotyping and genotyping of patients should be pursued further.